Reuters -- U.S. firm Impax Laboratories Inc will be able to sell a generic version of Astellas Pharma’s Flomax prostate drug one month ahead of its U.S. patent expiry under a settlement agreement.
Reuters -- U.S. firm Impax Laboratories Inc will be able to sell a generic version of Astellas Pharma’s Flomax prostate drug one month ahead of its U.S. patent expiry under a settlement agreement.
